Literature DB >> 26672645

Cannabinoids in the Treatment of Epilepsy.

Daniel Friedman, Orrin Devinsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26672645     DOI： 10.1056/NEJMc1512758

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

1.  Stakeholders' Views on Barriers to Research on Controversial Controlled Substances.

Authors:  Evelyn Rhodes; Michael Andreae; Tyler Bourgiose; Debbie Indyk; Rosamond Rhodes; Henry Sacks
Journal:  J Clin Ethics       Date:  2016

Review 2.  Pros and Cons of Medical Cannabis use by People with Chronic Brain Disorders.

Authors:  Uma Suryadevara; Dawn M Bruijnzeel; Meena Nuthi; Darin A Jagnarine; Rajiv Tandon; Adriaan W Bruijnzeel
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

Review 3.  Up to What Extent Does Dravet Syndrome Benefit From Neurostimulation Techniques?

Authors:  Jiangwei Ding; Lei Wang; Wenchao Li; Yangyang Wang; Shucai Jiang; Lifei Xiao; Changliang Zhu; Xiaoyan Hao; Jiali Zhao; Xuerui Kong; Ziqin Wang; Guangyuan Lu; Feng Wang; Tao Sun
Journal:  Front Neurol       Date:  2022-04-13       Impact factor: 4.086
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.